Cardiovascular Protection After Preeclampsia With Enalapril

Part of paid clinical trials in Providence, Rhode Island.

Sponsor
Women and Infants Hospital of Rhode Island
Study ID
NCT07222852
Phase
PHASE3
Status
Recruiting
Apply to this trial

Conditions

  • Gestational Hypertension
  • Gestational Hypertension After Childbirth
  • Hypertension
  • Hypertensive Disorder of Pregnancy
  • Preeclampsia

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Enalapril — DRUG
    First-line anti-hypertensive treatment with enalapril
  • Standard treatment — OTHER
    First-line anti-hypertensive treatment per standard of care

Study Details

The purpose of this study is to learn if postpartum women are willing to be randomized to different blood pressure medicines after delivery and how that affects blood pressure in women with hypertensive disorders of pregnancy.

Key Dates

First listed
Oct 30, 2025
Start date
Jan 1, 2026
Status verified
Apr 2026
Primary completion
Oct 15, 2027
Completion
Oct 15, 2027

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Enalapril
    First-line anti-hypertensive treatment with enalapril
  • Active Comparator: Standard treatment
    First-line anti-hypertensive treatment with standard of care treatment

Primary Outcome Measure

Feasibility of enrollment [ Time Frame: 4 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Women and Infants HospitalProvidenceRhode Island02906
Alisse Hauspurg, MD, MS
[email protected]
401-274-1122

Find similar trials in Providence, RI

Nationwide
Hypertension (high blood pressure) trialsCardiology trialsHeart disease trials
By condition
Hypertension (high blood pressure)
By specialty
CardiologyHeart disease
By research site
Women and Infants Hospital· Providence, RI

Related Studies